AGREEMENT AND PLAN OF MERGER BY AND AMONG ONCOGENERIX, INC., THE STOCKHOLDERS’ REPRESENTATIVE, THE PRINCIPAL STOCKHOLDERS, DARA BIOSCIENCES, INC. AND ONCOGENERIX ACQUISITION CORPORATION JANUARY 17, 2012Agreement and Plan of Merger • January 17th, 2012 • DARA BioSciences, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJanuary 17th, 2012 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made as of January 17, 2012, by and among Oncogenerix, Inc., a Nevada corporation (the “Company”); the stockholders of the Company listed on the signatures pages hereto (the “Principal Stockholders”); Christopher Clement, in his capacity as the Stockholders’ Representative; DARA BioSciences, Inc., a Delaware corporation (the “Buyer”); and Oncogenerix Acquisition Corporation, a Nevada corporation (the “Merger Sub”). The Company, the Principal Stockholders, the Stockholders’ Representative, the Buyer and the Merger Sub are each referred to herein as a “Party” and collectively as the “Parties.”
EMPLOYMENT AGREEMENTEmployment Agreement • January 17th, 2012 • DARA BioSciences, Inc. • Pharmaceutical preparations • North Carolina
Contract Type FiledJanuary 17th, 2012 Company Industry JurisdictionThis Employment Agreement (this “Agreement”) is made as of January 17, 2012 (the “Effective Date”) by and between DARA BioSciences, Inc., a Delaware corporation (the “Company”), and Christopher Clement (the “Executive”).